Malling Hans-Jørgen, Hansen Kirsten Skamstrup, Halken Susanne, Curtz Anne Caroline, Schmid Johannes, Mosbech Holger
Klinik for Allergi, Hud- og Kønssygdomme, Københavns Universitetshospital - Herlev og Gentofte Hospital.
Afdeling for Børn og Unge, Københavns Universitetshospital - Herlev og Gentofte Hospital.
Ugeskr Laeger. 2025 Jun 16;187(25):V09240593. doi: 10.61409/V09240593.
This review finds that diagnostics should only be performed in patients who might be candidates for venom immunotherapy (VIT). VIT is recommended for children and adults with documented sensitisation and systemic anaphylactic reactions (respiratory and/or circulatory symptoms) or reduced quality of life due to less severe reactions. VIT is not recommended for children with monosymptomatic urticaria. VIT should be continued for five years. Patients should carry an adrenaline autoinjector during insect season until a maintenance dose is reached.
本综述发现，仅应对可能适合进行毒液免疫疗法（VIT）的患者进行诊断。VIT适用于有明确致敏和全身性过敏反应（呼吸和/或循环系统症状）或因不太严重的反应导致生活质量下降的儿童和成人。不建议对仅有症状性荨麻疹的儿童使用VIT。VIT应持续五年。在昆虫季节，患者应随身携带肾上腺素自动注射器，直至达到维持剂量。
